Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
7.24
+0.21 (2.99%)
At close: Apr 28, 2026, 4:00 PM EDT
7.27
+0.03 (0.41%)
Pre-market: Apr 29, 2026, 7:47 AM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $759.39 million as of April 29, 2026. Its market cap has increased by 7,648.89% in one year.
Market Cap
759.39M
Enterprise Value
666.38M
1-Year Change
7,648.89%
Ranking
Category
Stock Price
$7.24
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $759.39M, an increase of 1,241.68%. That is a compound annual growth rate of 27.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 759.40M | 114.40% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 800.94M |
| Cullinan Therapeutics | 800.16M |
| Allogene Therapeutics | 794.59M |
| SpyGlass Pharma | 786.19M |
| Solid Biosciences | 779.29M |
| Design Therapeutics | 772.75M |
| Vor Biopharma | 748.30M |
| Tenax Therapeutics | 719.30M |